| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/CCO.0B013E3282F0ADA3 |
| P698 | PubMed publication ID | 17906450 |
| P2093 | author name string | Shannon R Morris | |
| Lisa A Carey | |||
| P2860 | cites work | Genomic signatures to guide the use of chemotherapeutics. | Q34576027 |
| P433 | issue | 6 | |
| P304 | page(s) | 547-551 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Current Opinion in Oncology | Q1909046 |
| P1476 | title | Gene expression profiling in breast cancer | |
| P478 | volume | 19 |
| Q37345122 | "New" molecular taxonomy in breast cancer |
| Q40364215 | Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020. |
| Q33410835 | Biological convergence of cancer signatures |
| Q37035343 | Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? |
| Q34479003 | Characteristics of triple-negative breast cancer |
| Q37214951 | Clinical utility of microarrays: current status, existing challenges and future outlook |
| Q28743801 | Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer |
| Q38736789 | Early gene expression changes with rush immunotherapy |
| Q38613315 | Effect of BRCA2 mutation on familial breast cancer survival: A systematic review and meta-analysis |
| Q50439039 | Elastographic features of triple negative breast cancers. |
| Q34677690 | Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy |
| Q37124483 | Improving communication of breast cancer recurrence risk |
| Q38427565 | Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. |
| Q34982782 | Renal gene and protein expression signatures for prediction of kidney disease progression |
| Q35638695 | Staging of breast cancer in the neoadjuvant setting |
| Q34267902 | Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience |
| Q33604808 | The transcription factor REST is lost in aggressive breast cancer |
| Q28077243 | Triple-negative breast cancer: is there a treatment on the horizon? |
| Q37634220 | Understanding breast cancer - The long and winding road |
| Q36503688 | Understanding how breast cancer patients use risk information from genomic tests |
Search more.